Sun Pharmaceutical Industries Share Price Today - Live Blog for July 10, 2025

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.11% increase and currently trading at ₹1,663.70 per share. This upward trajectory is turning heads in the market.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.13% slump and is currently trading at ₹1,661.35. While the stock maintains a PE ratio of 36.6000, the industry PE is 35.0068, raising questions about valuation.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.12%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,662.20, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd experienced a -0.12% downturn in its share price, and it's currently trading at ₹1,662.20. This situation is generating interest among value investors who are evaluating the stock's potential.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.07%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,664.20, but investors are assessing whether this is a temporary dip or a long-term trend.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.13% increase and currently trading at ₹1,664.60 per share. Investors are taking notice of this upward momentum.

The share price of Sun Pharmaceutical Industries Ltd experienced an impressive 0.13% upswing and is currently trading at ₹1,664.60, indicating strong market sentiment.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.02%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,662.40, and market participants are assessing the implications. The stock has a PE ratio of 36.6000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Following a noteworthy 0.09% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,662.45. When it comes to valuation, this stock has a PE ratio of 36.6000, with the industry PE ratio at 35.0068.

With a remarkable 0.06% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,660.95. Notably, this stock has a Price-to-Earnings (PE) ratio of 36.6000, while the industry's PE ratio is 35.0068.

With a remarkable 0.14% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,660.00. Notably, this stock has a Price-to-Earnings (PE) ratio of 36.6000, while the industry's PE ratio is 35.0068.

Sun Pharmaceutical Industries Ltd witnessed a -0.06% drop in its share price and is currently trading at ₹1,655.95. With the stock's PE at 36.6000 and the industry PE at 35.0068, investors are weighing their options.

Sun Pharmaceutical Industries Ltd observed a -0.06% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,655.95. The stock has a PE ratio of 36.6000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.06%, with the current market value at ₹1,655.95 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.02%, reaching the current market price of ₹1,655.95. This development underscores the stock's growing popularity.

Sun Pharmaceutical Industries Ltd share price has declined by -0.06%, and it's currently trading at ₹1,655.45. The stock maintains a PE of 36.6000, while the industry PE is 35.0068, prompting discussions about its valuation.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.06%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,656.50 per share.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.42%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,655.50 per share.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.01% surge in its share price and is presently trading at ₹1,648.60. The increased investor interest is driving this surge.

Sun Pharmaceutical Industries Ltd's share price remained the same, currently trading at ₹1,650.30. This unchanging trend might prompt investors to reevaluate their investment thesis and consider factors influencing the stock's stability.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.14% slump and is currently trading at ₹1,650.30. While the stock maintains a PE ratio of 36.6000, the industry PE is 35.0068, raising questions about valuation.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.27%, a development that warrants careful analysis. Presently trading at ₹1,651.50, investors are assessing whether this presents an opportunity or a risk.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.18%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,656.00, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.08%, with the current market value at ₹1,658.60 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.17%, reaching the current market price of ₹1,661.55. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd witnessed a -0.28% drop in its share price and is currently trading at ₹1,658.70. With the stock's PE at 36.6000 and the industry PE at 35.0068, investors are weighing their options.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.36%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,663.95, and market participants are assessing the implications. The stock has a PE ratio of 36.6000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.